ExpreS2ion Biotech Holding AB (EXPRS2) — Net Asset Quality Index
ExpreS2ion Biotech Holding AB (EXPRS2) has a Net Asset Quality Index of 52.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr50.40 Million minus total liabilities of Skr23.98 Million yields net assets of Skr26.42 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read ExpreS2ion Biotech Holding AB (EXPRS2) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
ExpreS2ion Biotech Holding AB Net Asset Quality Index Over Time (2013–2025)
This chart shows how ExpreS2ion Biotech Holding AB's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 52.4%, representing net assets of Skr26.42 Million against total assets of Skr50.40 Million SEK. For live market cap and overall valuation, see market cap of ExpreS2ion Biotech Holding AB.
Annual Net Asset Quality Index for ExpreS2ion Biotech Holding AB (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for ExpreS2ion Biotech Holding AB from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check ExpreS2ion Biotech Holding AB strategic capital allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 54.8% | Skr35.69 Million | Skr65.11 Million | Skr29.42 Million | ▼ -6.8 pp |
| 2024 | 61.6% | Skr64.42 Million | Skr104.53 Million | Skr40.11 Million | ▼ -21.4 pp |
| 2023 | 83.1% | Skr65.36 Million | Skr78.69 Million | Skr13.33 Million | ▲ +7.8 pp |
| 2022 | 75.2% | Skr103.33 Million | Skr137.36 Million | Skr34.04 Million | ▼ -17.1 pp |
| 2021 | 92.4% | Skr140.35 Million | Skr151.96 Million | Skr11.61 Million | ▲ +12.8 pp |
| 2020 | 79.5% | Skr94.55 Million | Skr118.86 Million | Skr24.31 Million | ▲ +85.3 pp |
| 2019 | -5.8% | Skr-1.08 Million | Skr18.71 Million | Skr19.79 Million | ▼ -45.4 pp |
| 2018 | 39.6% | Skr8.30 Million | Skr20.95 Million | Skr12.65 Million | ▲ +0.5 pp |
| 2017 | 39.1% | Skr6.74 Million | Skr17.23 Million | Skr10.50 Million | ▼ -13.2 pp |
| 2016 | 52.3% | Skr12.88 Million | Skr24.61 Million | Skr11.73 Million | ▲ +199.1 pp |
| 2015 | -146.8% | Skr-6.01 Million | Skr4.09 Million | Skr10.10 Million | ▼ -189.6 pp |
| 2014 | 42.8% | Skr2.35 Million | Skr5.48 Million | Skr3.13 Million | ▼ -4.2 pp |
| 2013 | 47.0% | Skr1.93 Million | Skr4.11 Million | Skr2.18 Million | — |